| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention belongs to pharmaceutical chemistry and medicine, refers to pharmaceutical composition for treatment of cardiovascular and nervous systems diseases as well as diseases connected with mitochondrial energetics and free radical formation disorders; invention includes active agent - 6-decaprenyl-2,3-dimethoxy-5-methyl-1,4-benzochinon, anionic surfactant, oil- and/or water-soluble emulsion stabiliser, water, powder; invention also refers to composition-obtaining method. ^ EFFECT: invention ensures obtaining of steady powder-composition of high biological availability, storage-stable during 39 months. ^ 4 cl, 1 tbl, 4 ex |
